Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors.
about
Eag and HERG potassium channels as novel therapeutic targets in cancerPhysical and functional interaction of KV10.1 with Rabaptin-5 impacts ion channel traffickingVoltage-gated potassium channel EAG2 controls mitotic entry and tumor growth in medulloblastoma via regulating cell volume dynamicsVoltage-gated ion channels in cancer cell proliferationStructure of the voltage-gated K⁺ channel Eag1 reveals an alternative voltage sensing mechanismEag1 channels as potential early-stage biomarkers of hepatocellular carcinomaIon Channels in Brain MetastasisHuman EAG channels are directly modulated by PIP2 as revealed by electrophysiological and optical interference investigationsRapid internalization of the oncogenic K+ channel K(V)10.1Functional K(v)10.1 channels localize to the inner nuclear membraneBehavioural and functional characterization of Kv10.1 (Eag1) knockout miceSilencing of Ether à go-go 1 by shRNA inhibits osteosarcoma growth and cell cycle progressionPositive correlation between the expression of hEag1 and HIF-1α in breast cancers: an observational study.The potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemiaTranscriptional and post-transcriptional mechanisms for oncogenic overexpression of ether à go-go K+ channel.Targeting potassium channels in cancerOxidative modulation of voltage-gated potassium channels.Potassium channel ether à go-go1 is aberrantly expressed in human liposarcoma and promotes tumorigenesisLong-term channel block is required to inhibit cellular transformation by human ether-à-go-go-related gene (hERG1) potassium channels.In vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors.Sig1R protein regulates hERG channel expression through a post-translational mechanism in leukemic cells.Cancer as a channelopathy: ion channels and pumps in tumor development and progressionAnalysis of the expression of Kv10.1 potassium channel in patients with brain metastases and glioblastoma multiforme: impact on survival.Overexpression of KCNJ3 gene splice variants affects vital parameters of the malignant breast cancer cell line MCF-7 in an opposing manner.Alternatively Spliced Isoforms of KV10.1 Potassium Channels Modulate Channel Properties and Can Activate Cyclin-dependent Kinase in Xenopus Oocytes.Short Hairpin RNA (shRNA) Ether à go-go 1 (Eag1) inhibition of human osteosarcoma angiogenesis via VEGF/PI3K/AKT signaling.Expression of eag1 channel associated with the aggressive clinicopathological features and subtype of breast cancer.p38 MAPK regulates the expression of ether à go-go potassium channel in human osteosarcoma cells.Guiding TRAIL to cancer cells through Kv10.1 potassium channel overcomes resistance to doxorubicin.In vivo imaging of tumour xenografts with an antibody targeting the potassium channel Kv10.1.Voltage-gated potassium channels as therapeutic targets.Eag1 K+ Channel: Endogenous Regulation and Functions in Nervous System.Pharmacological modulation of voltage-gated potassium channels as a therapeutic strategy.K(+) channels as therapeutic targets in oncology.Ion channels as targets for cancer therapyEag1 channels as potential cancer biomarkers.miRNA in the regulation of ion channel/transporter expression.The sigma-1 receptor: a regulator of cancer cell electrical plasticity?Potassium channels in cell cycle and cell proliferation.Functional properties of ion channels and transporters in tumour vascularization.
P2860
Q21245576-5A3012A0-0806-4B6A-8F6D-2A9C0468B896Q24294406-730268EA-727B-4A8A-9B3F-E5D6AA24F8D7Q24294672-8C4A8B16-4311-412E-84DE-8B01E98CF7A3Q27010511-16966870-08D7-445A-978B-0BD9584B8C9DQ27727293-5BC68E7B-F40C-480F-84B7-A7C0F4C0D9D2Q28069313-967DD667-9341-469F-8C16-9D1AD6FDEEFBQ28078185-BB5EBF89-D991-4F1F-85D6-994F0D8ECC68Q28118681-2A3E676C-6005-4AA7-AB37-2009D802430FQ28477472-B4774504-88E9-48E0-92A0-9544EAB5949EQ28571386-0410D2CB-AFC6-45D5-8155-D9A620C2D5E4Q30454673-DBB33C75-23C5-4CA8-9EC6-297B5732CCA1Q33580439-27A48B55-194B-49FE-BB26-D3C587401803Q33629346-F7987BE7-EE32-4199-88E4-E782D1469D49Q33715775-789D3B4B-6FF8-4BD6-A8E9-CD3F318AA857Q33927117-B1058A19-1B8C-428F-BC3D-329202C05738Q33937726-6C1D9DFE-4433-4BCE-A3D1-7DAE64C761C6Q33975038-D4160A1D-65FC-437B-839D-2116142E3C03Q34022525-3110DC50-DA92-4565-A35B-B97A010317A0Q34024653-9549DF8D-F7EA-41A1-9F8C-251F293FFD3CQ34325900-8DE3E20F-8963-4518-A925-2DD1D60059F0Q35150041-B1B5D3DB-7FE2-4D3D-80A8-66562244C012Q35184108-7B7D47D5-4BD4-417C-9651-28D94946E8E5Q35830894-0745C871-879D-4D7E-A3A4-82B6F1DA6863Q36103130-60CE5FC4-FA98-4A38-A795-7C2DBD316363Q36381917-83AA19B6-3343-4552-906C-4921A0643A69Q36396465-277EDEE0-7BAE-4090-AA2B-09E3DA9126B8Q36464823-164B9739-9C65-4B00-B876-C41575CD56A9Q36613887-52738973-BF67-4F00-AB5F-39D347F78640Q37302038-3065851F-D4BF-47CA-9D68-B16BA3639465Q37302048-7DE6E1FE-8F38-459C-B8D1-E337975E9852Q37464784-5BA0D344-D2AE-4268-85B6-184446956398Q37711718-5293389B-D7E7-466E-9963-F01AD43FBB35Q37781356-D26282AE-138C-4E72-824F-94984A09309BQ37855925-6B3293B1-45DD-46F0-BF2A-67878D3906B3Q37901394-5E9F7C41-84D5-44C5-AF79-7AFF2B48A8DFQ38025086-37EA599B-694F-4AF6-85D1-8D4BC8A80C55Q38110520-F01CAF48-BC68-4D8D-BE31-80AE2B6CBB5FQ38123807-1C8E2984-A082-4976-9572-D8936A59E8B6Q38184978-9488A535-C1D3-4BFF-A5D5-47BF35D2E7D6Q38184988-118D53D1-7706-482F-BB84-080AAF3571DF
P2860
Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors.
@en
Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors.
@nl
type
label
Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors.
@en
Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors.
@nl
prefLabel
Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors.
@en
Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors.
@nl
P2093
P2860
P356
P1476
Eag1 expression interferes with hypoxia homeostasis and induces angiogenesis in tumors.
@en
P2093
Araceli Sánchez
Bryan R Downie
Claudia Weber
Constanza Contreras-Jurado
Hendrik Knötgen
Luis A Pardo
Marco Gymnopoulos
Walter Stühmer
P2860
P304
36234-36240
P356
10.1074/JBC.M801830200
P407
P577
2008-10-16T00:00:00Z